ASX 200 wrap: 6 things to think about this weekend
The ASX 200 finished out the week higher, closing the session at 6,824 points.
ASX 200 ↑
The ASX 200 benchmark closed out Friday's session up 0.50% at 6,824 points.
This caps off a positive week for the Aussie index, with the ASX 200 gaining ~1.8% over the last five sessions.
You can trade indices like the ASX 200 – long or short – with IG. Create an account to get started now.
All Technology Index ↑
Elsewhere, the All Technology Index outperformed the ASX 200 on Friday, rising 1.12%, to trade at the 2,696 point level by the close.
Healthcare was the worst performing sector on Friday, while Telecommunications was the best performing. The healthcare sector was weighed down by CSL – with the biotech's share price closing 0.88% lower.
On Thursday, Macquarie analysts reiterated their Neutral rating on the biotech giant, while saying that Google data suggested that foot traffic across approximately 100 of CSL's US plasma collection centres had declined in recent times.
'We continue to see plasma collection as presenting risks in relation to the near-term outlook,' Macquarie said.
TPG Share Price ↓
Despite Telecommunications being the best performing sector during the session, TPG Telecom – one of Australia’s three key telcos – saw its share price sold of heavily. This comes after the company announced that David Teoh would be stepping down from his role as Chairman and Director of TPG’s Board.
Commenting on his time at the company, Mr Teoh said:
'I am proud and humbled to have led the company from its founding, through its exciting growth over the years, and most recently into its merger with Vodafone Hutchison Australia.'
‘There have been many challenges along the way, but I firmly believe that consumers in Australia have greatly benefited from TPG's competitive business approach, and that they will continue to do so.'
At the time of writing TPG was down 6.70% to $6.41 per share, well off its 52-week high of $9.70 per share.
On Thursday it was revealed that global exchange operator Cboe Global Markets had reached a deal to acquire Chi-X Asia Pacific – which includes Chi-X’s Australian and Japanese operations. Chi-X is a key competitor of the Australian Stock exchange – which remains the dominant player in the market.
Commenting on the deal, CBOE’s CEO, Ed Tilly, said:
‘With the planned acquisition of Chi-X Asia Pacific, we continue to execute on our growth strategy by broadening our geographic and asset class presence while enabling the further extension of our product offerings to our global network of customers.’
According to analysis from Morgan Stanley (MS), Chi-x has an approximate 20% market share of Australia’s cash equities trading.
‘Market share gains have stalled over the past 3 years, but we think ASX may face renewed competition,’ MS analysts added.
US Markets ↑
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Live prices on most popular markets